# Genentech, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec

> Inspection records and compliance data for Genentech, Inc. in South San Francisco, California. Access full analysis and detailed observations.

---

## Details

- Name: Genentech, Inc.
- FEI Number: 2917293
- City: South San Francisco
- State: California
- Country Name: United States
- Address Line 1: 1 Dna Way Bldg 5
- Zip Code: 94080
- Facility Type: Manufacturer

## Related Documents

- [CRL - Genentech, Inc. - Unknown Date](https://www.keypedia.com/records/crl/genentech-inc/82cfc039-6c70-459b-ad38-2e0ed36626fa) — source: FDA, date: Invalid Date
- [FDA Inspection 1314654 - Genentech, Inc. - 2026-04-07](https://www.keypedia.com/records/fda_inspections/genentech-inc/0baa8be9-4126-4df0-853d-23dc0ca6f7cc) — source: FDA, date: April 7, 2026
- [FDA Inspection 1263573 - Genentech, Inc. - 2025-04-21](https://www.keypedia.com/records/fda_inspections/genentech-inc/d1879b40-adc5-4e34-a983-95d715e0461e) — source: FDA, date: April 21, 2025
- [FDA Inspection 1263573 - Genentech, Inc. - 2025-04-21](https://www.keypedia.com/records/fda_inspections/genentech-inc/e8ddcafd-462a-415a-8e66-7f27b8209978) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2025
- [FDA Inspection 1236964 - Genentech, Inc. - 2024-05-02](https://www.keypedia.com/records/fda_inspections/genentech-inc/d7fa8583-d22f-424b-8e09-2c1404f53842) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2024
- [FDA Inspection 1236964 - Genentech, Inc. - 2024-05-02](https://www.keypedia.com/records/fda_inspections/genentech-inc/4351fc6f-c62f-4572-8b67-099e7db36d0a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2024
- [FDA Inspection 1235655 - Genentech, Inc. - 2024-03-20](https://www.keypedia.com/records/fda_inspections/genentech-inc/6b6012ce-24be-471f-8d57-85bb92f5fb25) — classification: No Action Indicated (NAI), source: FDA, date: March 20, 2024
- [483 - Genentech, Inc. - 2024-03-12](https://www.keypedia.com/records/483/genentech-inc/7887b305-0de6-472c-b596-8cbd94e8d300) — source: FDA, date: March 12, 2024
- [FDA Inspection 1233203 - Genentech, Inc. - 2024-03-12](https://www.keypedia.com/records/fda_inspections/genentech-inc/c630a432-31f9-476d-9f0d-9c7a9ed953d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 12, 2024
- [483 - Genentech, Inc. - 2023-08-11](https://www.keypedia.com/records/483/genentech-inc/ce85e9f0-3331-495a-b1b4-a7e2df5fa79b) — source: FDA, date: August 11, 2023
- [FDA Inspection 1214575 - Genentech, Inc. - 2023-08-11](https://www.keypedia.com/records/fda_inspections/genentech-inc/84a034a5-344a-46c2-9b20-5a05a08e407b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2023
- [FDA Inspection 1200732 - Genentech, Inc. - 2023-02-21](https://www.keypedia.com/records/fda_inspections/genentech-inc/810907e1-e784-4115-9e9a-3c66ad8287c7) — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2023
- [483 - Genentech, Inc. - 2023-02-02](https://www.keypedia.com/records/483/genentech-inc/b299d841-8699-4965-a70b-a57ce3508938) — source: FDA, date: February 2, 2023
- [FDA Inspection 1199184 - Genentech, Inc. - 2023-02-02](https://www.keypedia.com/records/fda_inspections/genentech-inc/eb828946-13a0-4a25-9b6c-b400ebf31cef) — source: FDA, date: February 2, 2023
- [483 - Genentech, Inc. - 2023-02-01](https://www.keypedia.com/records/483/genentech-inc/1cd09b7b-965e-44ed-b8cb-5c204ab45f19) — source: FDA, date: February 1, 2023
- [483 - Genentech, Inc. - 2023-01-31](https://www.keypedia.com/records/483/genentech-inc/e020acbc-f66e-4314-a8bc-c156ef8c9a94) — source: FDA, date: January 31, 2023
- [EIR - Genentech, Inc. - 2022-10-07](https://www.keypedia.com/records/eir/genentech-inc/c790563c-45ba-439c-8c24-6cd1f80fcf3f) — source: FDA, date: October 7, 2022
- [483 - Genentech, Inc. - 2022-05-26](https://www.keypedia.com/records/483/genentech-inc/3b630c1e-0dc5-44a8-a456-256f25c6a163) — source: FDA, date: May 26, 2022
- [EIR - Genentech, Inc. - 2016-09-16](https://www.keypedia.com/records/eir/genentech-inc/2b4ed0c8-e5f3-40aa-84e2-72d27b55d3b8) — source: FDA, date: September 16, 2016
- [483 - Genentech, Inc. - 2011-09-27](https://www.keypedia.com/records/483/genentech-inc/18f90c1b-4f69-4c48-99f7-a22fc019324c) — source: FDA, date: September 27, 2011

## Related Companies

- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [West Agro, Inc.](https://www.keypedia.com/companies/west-agro-inc/81d19178-2702-4936-9c7d-9264e476f1c6)
- [Pharmacia & Upjohn Company LLC](https://www.keypedia.com/companies/pharmacia-upjohn-company-llc/de0a9227-069b-44f4-a9b3-21db78c27480)
- [A. Nelson & Co., Ltd.](https://www.keypedia.com/companies/a-nelson-co-ltd/36fe9f82-7169-47d2-9e57-8ed77942c73d)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)

## Related Officers

- [company_representative](https://www.keypedia.com/people/lorraine-k-fay/0481f8a2-7630-4b31-b50f-4e6b652947a1)
- [company_representative](https://www.keypedia.com/people/daniel-oday/2784a05c-ad91-4437-8e4c-0d46265484d4)
- [investigator](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)
- [Sabina Zimmerman, PhD](https://www.keypedia.com/people/sabina-zimmerman-phd/6e49ea0a-9ea6-4249-be02-e70eb84e789b)